Medico Remedies Limited (BOM:540937)

Market Cap	3.62B +2.9%
Revenue (ttm)	2.38B +50.3%
Net Income	138.15M +33.7%
EPS	1.66 +33.0%
Shares Out	82.98M
PE Ratio	26.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,998
Open	46.42
Previous Close	45.01
Day's Range	43.10 - 46.42
52-Week Range	31.00 - 56.99
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 213
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540937

Financial Performance

In fiscal year 2026, Medico Remedies's revenue was 2.06 billion, an increase of 36.73% compared to the previous year's 1.51 billion. Earnings were 131.15 million, an increase of 29.94%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 17, 2026

Data Sources Report a data error